APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry
Belloy ME, Andrews SJ, Le Guen Y, Cuccaro M, Farrer LA, Napolioni V, Greicius MD. JAMA Neurology, 2023-12-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Results Among 68 756 unique individuals, analyses included 21 852 East Asian (demographic data not available), 5738 Hispanic (68.2% female; mean [SD] age, 75.4 [8.8] years), 7145 non-Hispanic Black (hereafter referred to as Black) (70.8% female; mean [SD] age, 78.4 [8.2] years), and 34 021 non-Hispanic White (hereafter referred to as White) (59.3% female; mean [SD] age, 77.0 [9.1] years) individuals. Deviating from the global pattern of ORs, APOE*22+23 was not associated with AD risk in East Asian individuals (OR, 0.97; 95% CI, 0.77-1.23). Global population ancestry could not explain why Hispanic individuals showed APOE associations with less pronounced AD risk compared with Black and White individuals. Within Black individuals, decreased global African ancestry or increased global European ancestry showed a pattern of APOE*4 dosage associated with increasing AD risk, but no such pattern was apparent for APOE*2 dosage with AD risk. The sex-by-age-specific interaction effect of APOE*34 among White individuals (higher risk in women) was reproduced but shifted to ages 60 to 70 years (OR, 1.48; 95% CI, 1.10-2.01) and was additionally replicated in a meta-analysis of Black individuals and Hispanic individuals (OR, 1.72; 95% CI, 1.01-2.94).
What this study adds
Evidence grade: High
This is a case-control study of 68,756 participants. A previously reported higher risk for women with the ε3/ε4 genotype was seen again in White individuals, but at ages 60 to 70 (OR 1.48), and also in a combined analysis of Black and Hispanic individuals (OR 1.72). Reported effect size: APOE ε3/ε4 vs ε3/ε3 odds ratio for AD: 4.54 East Asian, 3.46 White, 2.18 Black, 1.90 Hispanic.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Belloy, M. E., Andrews, S. J., Le Guen, Y., Cuccaro, M., Farrer, L. A., Napolioni, V., et al. (2023). APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2023.3599
Vancouver
Belloy ME, Andrews SJ, Le Guen Y, Cuccaro M, Farrer LA, Napolioni V, et al. APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry. JAMA Neurology. 2023. doi:10.1001/jamaneurol.2023.3599. PMID: 37930705.
BibTeX
@article{belloy2023-37930705,
author = {Belloy, M. E. and Andrews, S. J. and Le Guen, Y. and Cuccaro, M. and Farrer, L. A. and Napolioni, V. and Greicius, M. D.},
title = {{APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry}},
journal = {JAMA Neurology},
year = {2023},
doi = {10.1001/jamaneurol.2023.3599},
pmid = {37930705},
url = {https://doi.org/10.1001/jamaneurol.2023.3599}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Results Among 68 756 unique individuals, analyses included 21 852 East Asian (demographic data not available), 5738 Hispanic (68.2% female; mean [SD] age, 75.4 [8.8] years), 7145 non-Hispanic Black (hereafter referred to as Black) (70.8% female; mean [SD] age, 78.4 [8.2] years), and 34 021 non-Hispanic White (hereafter referred to as White) (59.3% female; mean [SD] age, 77.0 [9.1] years) individuals.
- Deviating from the global pattern of ORs, APOE*22+23 was not associated with AD risk in East Asian individuals (OR, 0.97; 95% CI, 0.77-1.23).
- Global population ancestry could not explain why Hispanic individuals showed APOE associations with less pronounced AD risk compared with Black and White individuals.
- Within Black individuals, decreased global African ancestry or increased global European ancestry showed a pattern of APOE*4 dosage associated with increasing AD risk, but no such pattern was apparent for APOE*2 dosage with AD risk.
- The sex-by-age-specific interaction effect of APOE*34 among White individuals (higher risk in women) was reproduced but shifted to ages 60 to 70 years (OR, 1.48; 95% CI, 1.10-2.01) and was additionally replicated in a meta-analysis of Black individuals and Hispanic individuals (OR, 1.72; 95% CI, 1.01-2.94).
Why it matters
In 68,756 East Asian, Hispanic, Black and White individuals, links between APOE genotype and Alzheimer disease differed by ancestry: the ε2 genotypes (ε2/ε2, ε2/ε3) showed no association with AD in East Asian people (OR 0.97), and Hispanic people showed weaker APOE associations that overall ancestry could not explain. A previously reported higher risk for women with the ε3/ε4 genotype was seen again in White individuals, but at ages 60 to 70 (OR 1.48), and also in a combined analysis of Black and Hispanic individuals (OR 1.72). These are statistical associations; they do not give anyone a personal risk figure and do not point to a treatment.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Study designcase-control
- Participants68,756
- Effect sizeAPOE ε3/ε4 vs ε3/ε3 odds ratio for AD: 4.54 East Asian, 3.46 White, 2.18 Black, 1.90 Hispanic
- Evidence strengthHigh
Limitations
Largely cross-sectional case-control data; effect estimates are approximate and depend on recruitment criteria of the aggregated cohorts rather than population-based samples; the study could not examine whether the weaker APOE associations in Black and Hispanic individuals reflect social determinants of health or modifiable risk factors.
How this study scored 82/100
Published in a leading specialty journal, and it is a case-control study. Scored zero for randomized / blinded because the record does not state it. We have no data on free to read, so that was left out: it earned 80 of the 98 points we could judge it on, which is 82 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (JAMA Neurology) |
| Journal's citation record | 2 / 4 | JAMA Neurology: journal h-index 235 (OpenAlex, 2026-10-29) |
| Study design | 6 / 12 | A case-control study |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2023 — within 6 year(s) of the newest study here |
| Sample size | 4 / 4 | 68,756 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 318 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 63.6 citations a year over 5 year(s) since 2023 |
| Impact for its field and year | 6 / 6 | Cited 46.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 36 other studies in this library |
| Still being cited | 4 / 4 | Cited 313 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Michael D. Greicius: h-index 65 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Stanford University: institution h-index 2,684 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 7 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 37930705) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 80 / 98 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 80 of the 98 points we could judge it on is 82 out of 100. |
| Total | 82 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/jamaneurol.2023.3599
- PubMed: 37930705
- Original source →
- Free full text: PubMed Central →
Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
36 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Genetics from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.